6Dispenzieri A, ArmitageJO, Loe MJ, et al. The clinical spectrum of Castleman's disease[]]. AmJ Hematol, 2012, 87(11):997-1002.
7Fajgenbaum D, Rosenbach M, van Rhee F, et al. Eruptive cherry hemangiomatosis associated with multicentric Casfleman disease: a case report and diagnostic clue[]].J Am Acad Dermatol, 2013, 149 (2) :204-208.
8E1--Osta HE, Kurzrock R. Castleman's disease: From basic mecha-nisms to molecular therapeutics[J]. Oncologist, 2011, 16 (4) :497-511.
9Polizzotto MN, Uldrick TS, Hu D, et al. Clinical manifestations of Kaposi sarcoma herpesvirus lyric activation: mulricentric Castle- man disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome[J]. Front Microbiol, 2012, 3:73.
10Fukumoto H, Kanno T, Hasegawa H, et al. Pathology of Kaposi's sarcoma-associated herpesvirus infection[J]. Front Microbiol, 2011, 2:175.
